Melanie De Almeida

Melanie De Almeida

Antag-Therapeutics-Startup-Obesity

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

30/06/2017
Pharmaleads-PL265-pain-Phase-I

New Drug for Neuropathic Pain Is Forging its Way through the Clinic

29/06/2017
refresh-antoine-papiernik-keynote

Video: The Next Big Thing in Biotech according to Sofinnova’s Antoine Papiernik

28/06/2017
Carbios-TechnipFMC-PET-Recycling

Green Biotech Enters Partnership to Advance the Infinite Recycling of Plastics

27/06/2017
Verona-Pharma-RPL554-COPD-Phase-IIb

Potential Breakthrough Treatment for Deadly Lung Disease to Advance into Phase IIb

27/06/2017
Rheumatoid Arthritis

UPDATE: EMA joins FDA in Approving Rheumatoid Arthritis Drug from Sanofi and Regeneron

27/06/2017
OSE-Tedopi-NSCLC-Phase-III

French Cancer Vaccine Stumbles in Phase III as Patient Accrual is Halted

26/06/2017
Osivax-Imaxio-Vaccines

This Newly Founded French Biotech is All About Vaccines

23/06/2017
Novartis-Cardiovascular-Canakinumab-Phase-III

Novartis Scores Major Phase III Win with New Cardiovascular Drug

22/06/2017
Refresh Oxitec Hadyn Perry

Video: Can Synbio Cure Malaria? – Fireside Chat with Oxitec’s CEO Hadyn Parry

21/06/2017
Cell Medica Catapult TCR Therapy Acquisition

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

21/06/2017
Novartis-AMD-RTH258-Phase-III

Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials

20/06/2017